Haleon (HLN) Tax Provisions (2021 - 2025)

Haleon's (HLN) quarterly Tax Provisions came in at $351.0 million in Q4 2025, up 180.35% on a QoQ basis from -$436.9 million in Q4 2023.

Haleon (HLN) Tax Provisions (2021 - 2025) Analysis & Trends

Haleon (HLN) has 4 years of Tax Provisions data on file, last reported at $351.0 million in Q4 2025.

Quarterly Tax Provisions changed N/A year-over-year to $351.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$370.0 million (changed N/A YoY) and the FY2025 annual result came in at $627.8 million, up 12.91% from the prior year.
Tax Provisions rose to $351.0 million in Q4 2025, from -$436.9 million in the prior quarter.
In the past five years, Tax Provisions ranged from a high of $351.0 million in Q4 2025 to a low of -$527.8 million in Q4 2022.
A 4-year average of -$250.2 million and a median of -$394.0 million in 2022 frame the typical range for Tax Provisions.
Annual changes were most pronounced in 2022 — Tax Provisions slipped 14.82% — and 2023, when it grew 17.23%.
Tracing HLN's Tax Provisions over 4 years: stood at -$459.7 million in 2021, then dropped by 14.82% to -$527.8 million in 2022, then grew by 17.23% to -$436.9 million in 2023, then soared by 180.35% to $351.0 million in 2025.
The last three Tax Provisions figures came in at $351.0 million (Q4 2025), -$436.9 million (Q4 2023), and -$128.9 million (Q2 2023), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Taxes (Qtr)
1	Haleon	43.76 Bn	42.80 Bn	-	-
2	Teva Pharmaceutical Industries	43.05 Bn	39.39 Bn	2.15 Bn	121.00 Mn
3	Zoetis	31.51 Bn	29.84 Bn	1.05 Bn	-
4	Takeda Pharmaceutical	28.70 Bn	22.90 Bn	5.10 Bn	-310.32 Mn
5	United Therapeutics	22.27 Bn	19.61 Bn	683.80 Mn	39.70 Mn
6	Viatris	18.83 Bn	17.95 Bn	1.46 Bn	54.80 Mn
7	Neurocrine Biosciences	15.65 Bn	15.26 Bn	935.80 Mn	17.80 Mn
8	Elanco Animal Health	12.06 Bn	11.53 Bn	798.00 Mn	2.00 Mn
9	Dr Reddys Laboratories	10.12 Bn	9.95 Bn	-	-
10	Alkermes	8.27 Bn	7.61 Bn	397.90 Mn	-2.40 Mn

Download Data